Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

OYSTER POINT PHARMA, INC.

(OYST)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart OYSTER POINT PHARMA, INC.
Upcoming events on OYSTER POINT PHARMA, INC.
03/03/22 FY 2021 Earnings Release (Projected)
05/16/22 Q1 2022 Earnings Release (Projected)
08/10/22 Interim 2022 Earnings Release (Projected)
12/06/22 Q3 2022 Earnings Release (Projected)
Past events on OYSTER POINT PHARMA, INC.
01/12/22 | 05:15pm JP Morgan Healthcare Conference
01/05/22 LifeSci Partners Corporate Access Event
12/02/21 Piper Sandler Healthcare Conference
11/14/21 | 04:45pm American Academy of Ophthalmology Meeting
11/14/21 | 09:48am American Academy of Ophthalmology Meeting - ONSET-2 Phase 3 Trial of OC-01
11/12/21 American Academy of Ophthalmology Meeting
11/04/21 | 03:30pm Q3 2021 Earnings Call
11/04/21 American Academy of Optometry Meeting - Effect of OC-01
11/04/21 American Academy of Optometry Meeting - Safety Assessment of OC-01
11/04/21 American Academy of Optometry Meeting
Past dividends on OYSTER POINT PHARMA, INC.

- No events available -

Annual results
Fiscal Period : December201920202021
Sales
M $
Released
Forecast
Spread


 


 
 
18,4
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-47,3
-32,3
-46%
-70,4
-69,8
-0,96%
 
-96,7
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-47,3
-32,3
-46%
-70,5
-69,9
-0,90%
 
-95,7
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-45,7
-31,0
-47%
-70,5
-69,5
-1,5%
 
-96,2
 
Net income
M $
Released
Forecast
Spread
-45,7
-31,2
-47%
-70,5
-69,7
-1,2%
 
-96,7
 
EPS
$
Released
Forecast
Spread
-2,29
-1,79
-28%
-2,92
-2,69
-8,4%
 
-3,83
 
Announcement Date02/27/202002/18/2021-
Quarterly results
Fiscal Period : December2020 Q32020 Q42021 Q12021 Q22021 Q32021 Q4
Sales
M $
Released
Forecast
Spread


 


 


 


 
17,9

 
 
0,50
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-16,3
-20,0
18%
-21,8
-21,0
-3,6%
-18,9
-24,0
21%
-22,0
-21,0
-4,7%
-16,7
-30,0
44%
 
-39,0
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-16,3
-19,0
14%
-22,2
-21,2
-5,2%
-18,9
-23,5
19%
-22,0
-21,0
-4,9%
-16,8
-31,5
47%
 
-37,4
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-16,3
-19,0
14%
-22,2
-21,4
-4,1%
-18,9
-23,5
20%
-22,0
-21,0
-4,8%
-17,7
-31,5
44%
 
-38,0
 
Net income
M $
Released
Forecast
Spread
-16,3
-19,0
14%
-22,2
-21,4
-4,1%
-18,9
-23,5
20%
-22,0
-21,0
-4,8%
-17,7
-31,5
44%
 
-38,0
 
EPS
$
Released
Forecast
Spread
-0,63
-0,74
15%
-0,86
-0,79
-9,2%
-0,73
-0,91
20%
-0,85
-0,85
-0,39%
-0,68
-1,16
41%
 
-1,38
 
Announcement Date11/05/202002/18/202105/06/202108/05/202111/04/2021-
Previous year Next Year
Upcoming sector events for OYSTER POINT PHARMA, INC.
More events
Past sector events for OYSTER POINT PHARMA, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise